ArticleNPJ precision oncology2026

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Kathrin B Labrosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.